[BUG] Broken concurrency: one cannot run few molecule processes in parallel

[webknjaz]

Issue Type

• Bug report

Molecule and Ansible details

devel

Molecule installation method (one of):

N/A

Ansible installation method (one of):

N/A

Detail any linters or test runners used:

docker driver

Desired Behavior

Molecule should create resources (test envs) with names unique to test run.
I want to be able to run concurrently the test of Molecule itself.

Actual Behaviour

Molecule's default docker image instance name defaults to the driver name, that's it. So when you run multiple processes they mess with the same resource breaking each other in unpredictable ways.

[decentral1se]

It looks like a work-around for this is in a0627fd, right?

[ragingpastry]

Ran into this a while back like lwm pointed out. There is probably a much better way to solve it though.

[webknjaz]

@lwm yea, kinda.
Also, see a prototype of the possible fix: webknjaz@87ccd81

[decentral1se]

Fix looks legit @webknjaz! How do you want to proceed? The CI should be able to verify this as working or we need to do some manual testing? Just to mark, I'll need to update #1683 documentation when we have this working differently.

[webknjaz]

@lwm thanks, feel free to fork from that branch (master...webknjaz:feature/molecule-parallelism) or cherry-pick it if you need this done fast because I'm not going to have time for it during the next few weeks. It seems fine but I don't like that it's a bit sketchy (and I'd normally add docstrings before merging such thing).
I think CI would probably be flaky with xdist enabled if the issue still exists but yes, if checked manually I'd be more confident.

In general, it's more about seeking the design feedback: is it fine to add such random thing to identifier names? what else would this affect? I checked with docker but what about other providers? do existing users rely on having the same instance name across subsequent re-runs (current patch would break this expectation because the random thing would be different every time)? what else did I miss? any UX problems?

[decentral1se]

Related: #1716 + #1704.

[hugoShaka]

It is interesting, and way cleaner that I've done on hugoShaka@b335b09 which was provider-specific 👏

I don't know what to think about the UUID thing. I guess it's the best solution if you need to run the same scenario in parallel on the same machine/cluster (I'm not sure about the use-case, maybe if you add some random and want to do stats). If you don't need to run the same scenario in parallel maybe using the scenario name as a prefix makes more sense for debugging purposes.

[decentral1se]

In general, it's more about seeking the design feedback: is it fine to add such random thing to identifier names? what else would this affect? I checked with docker but what about other providers? do existing users rely on having the same instance name across subsequent re-runs (current patch would break this expectation because the random thing would be different every time)? what else did I miss? any UX problems?

Right, good points. I think molecule users are expecting their instances to be named the way they see them in the molecule.yml, so maybe we're going down the wrong path. See, for example, #1731 and also the CLI of molecule login --host {instance-name}.